Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024)

Updated

Abvc Biopharma's Short-Term Debt issuances was $30,000 in FY2024.

Analysis

Abvc Biopharma (ABVC) Short-Term Debt issuances (2018 - 2024) Analysis & Trends

From FY2018 onward, Abvc Biopharma has reported Short-Term Debt issuances for 6 years.

  • Short-Term Debt issuances shows a five-year compound annual growth rate of -50.4% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Short-Term Debt issuances since FY2021.
  • Per Business Quant data, Short-Term Debt issuances in earlier years was $350,000 in FY2022, $4,265 in FY2021 (-95.7%) and $100,000 in FY2020 (-90.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.28 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 30,000.00
Mar 31, 2021 10,651.00
Jun 30, 2020 -180,940.00
Mar 31, 2020 280,940.00
Dec 31, 2019 153,700.00
Sep 30, 2019 -153,700.00
Dec 31, 2018 49,008.00
Sep 30, 2018 75,990.00
Jun 30, 2018 -256,550.00
Mar 31, 2018 312,824.00
API Access

Abvc Biopharma Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=ABVC&period=max&api_key=YOUR_API_KEY